Rashmi Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.51 Cr
as on 24-10-2024
- Company Age 25 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.81 Cr
as on 24-10-2024
- Satisfied Charges ₹ 5.78 Cr
as on 24-10-2024
- Revenue 8.51%
(FY 2023)
- Profit -38.33%
(FY 2023)
- Ebitda 8.61%
(FY 2023)
- Net Worth 57.89%
(FY 2023)
- Total Assets 9.60%
(FY 2023)
About Rashmi Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 1.51 Cr.
The company currently has active open charges totaling ₹6.81 Cr. The company has closed loans amounting to ₹5.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gundrati Jagannath, Gundrathi Prasuna, Gundrati Bharath, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239TG1999PTC031538
- Company No.
031538
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Rashmi Pharma Private Limited offer?
Rashmi Pharma Private Limited offers a wide range of products and services, including Pharmaceutical Medicine, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Pharmaceutical Drug.
Who are the key members and board of directors at Rashmi Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gundrati Jagannath  | Managing Director | 19-Apr-1999 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gundrathi Prasuna | Whole-Time Director | 19-Apr-1999 | Current |
| Gundrati Bharath | Additional Director | 10-Aug-2024 | Current |
| Gundrathi Rashmi | Additional Director | 29-May-2024 | Current |
Financial Performance of Rashmi Pharma.
Rashmi Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.51% increase. The company also saw a substantial fall in profitability, with a 38.33% decrease in profit. The company's net worth Soared by an impressive increase of 57.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rashmi Pharma?
In 2023, Rashmi Pharma had a public holding of 6.62%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 19 Aug 2023 | ₹2.45 M | Open |
State Bank Of India Creation Date: 18 Mar 2016 | ₹6.56 Cr | Open |
Kotak Mahindra Bank Limited Creation Date: 21 Jan 2015 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Rashmi Pharma?
Rashmi Pharma has a workforce of 46 employees as of May 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rashmi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rashmi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
